Search Results - "Cisneros Herreros, J.M"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Differences in Cytomegalovirus Replication Quantified Using Quantitative Polymerase Chain Reaction and Antigenemia After Allogeneic Stem Cell Transplantation by de la Cruz-Vicente, F, Perez-Romero, P, Aguilar-Guisado, M, Cisneros-Herreros, J.M, Urbano-Ispizua, A, Espigado, I

    Published in Transplantation proceedings (01-10-2010)
    “…Abstract Fifty percent of allogeneic stem cell recipients develop cytomegalovirus (CMV) infection in the first 100 days posttransplantation. Various methods…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Clinical Utility of Real-Time Polymerase Chain Reaction to Quantify Cytomegalovirus Replication in Allogeneic Stem Cell Transplant Recipients With Different Prevention Strategies by De la Cruz-Vicente, F, Perez-Romero, P, Aguilar-Guisado, M, Cisneros-Herreros, J.M, Urbano-Ispizua, A, Espigado, I

    Published in Transplantation proceedings (01-10-2010)
    “…Abstract Cytomegalovirus (CMV) end-organ disease is a serious, frequent complication after allogenic stem cell transplantation (Allo-SCT). There are two…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Preemptive Therapy for Cytomegalovirus Disease in Allogeneic Stem Cell Transplant Recipients by de la Cruz-Vicente, F, Cerezuela Martinez, P, Gil-Espárraga, E, Martin Aguilera, C, Aguilar Guisado, M, Parody Ruiz-Berdejo, R, Cisneros Herreros, J.M, Urbano-Ispizua, A, Espigado Tocino, I

    Published in Transplantation proceedings (01-11-2008)
    “…Abstract Cytomegalovirus (CMV) infection causes high morbidity and mortality among allogeneic stem cell transplant recipients. Preemptive therapy with oral…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Therapeutic armamentarium against systemic fungal infections by Cisneros Herreros, J.M., Cordero Matía, E.

    Published in Clinical microbiology and infection (01-12-2006)
    “…The incidence of invasive fungal infections (IFIs) has been following an upward trend over time, due to a continuous increase in the number of patients at…”
    Get full text
    Journal Article
  5. 5

    Piperacilina-tazobactam en perfusión continua o expandida frente a perfusión intermitente by Acosta García, H., Victoria Gil-Navarro, M., Cotrina Luque, J., Cisneros Herreros, J.M., Lepe Jiménez, J.A., Bautista Paloma, J.

    Published in Farmacia hospitalaria (01-09-2012)
    “…El objetivo principal de esta revisión es analizar las diferencias de eficacia entre la administración en perfusión intermitente y la administración en…”
    Get full text
    Journal Article